Skip to main content

Publications

Found 134 results
Author Title [ Year(Asc)]
Filters: Keyword is Pregnancy  [Clear All Filters]
2016
Ramadurg U, Vidler M, Charanthimath U, Katageri G, Bellad M, A M, et al.. Community health worker knowledge and management of pre-eclampsia in rural Karnataka State, India. Reprod Health. 2016;13(Suppl 2):113.  (629.01 KB)
Sotunsa J, Vidler M, Akeju D, Osiberu M, Orenuga E, Oladapo O, et al.. Community health workers' knowledge and practice in relation to pre-eclampsia in Ogun State, Nigeria: an essential bridge to maternal survival. Reprod Health. 2016;13(Suppl 2):108.  (287.53 KB)
Akeju D, Vidler M, Oladapo O, Sawchuck D, Qureshi R, von Dadelszen P, et al.. Community perceptions of pre-eclampsia and eclampsia in Ogun State, Nigeria: a qualitative study. Reprod Health. 2016;13 Suppl 1:57.  (838.19 KB)
Boene H, Vidler M, Sacoor C, Nhama A, Nhacolo A, Bique C, et al.. Community perceptions of pre-eclampsia and eclampsia in southern Mozambique. Reprod Health. 2016;13 Suppl 1:33.  (1.01 MB)
Vidler M, Charanthimath U, Katageri G, Ramadurg U, Karadiguddi C, Sawchuck D, et al.. Community perceptions of pre-eclampsia in rural Karnataka State, India: a qualitative study. Reprod Health. 2016;13 Suppl 1:35.  (810.48 KB)
Firoz T, Vidler M, Makanga P, Boene H, Chiaú R, Sevene E, et al.. Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study. Reprod Health. 2016;13(Suppl 2):112.  (1019.85 KB)
Khowaja A, Qureshi R, Sheikh S, Zaidi S, Salam R, Sawchuck D, et al.. Community's perceptions of pre-eclampsia and eclampsia in Sindh Pakistan: a qualitative study. Reprod Health. 2016;13 Suppl 1:36.  (398.75 KB)
Chou D, Tunçalp Ö, Firoz T, Barreix M, Filippi V, von Dadelszen P, et al.. Constructing maternal morbidity - towards a standard tool to measure and monitor maternal health beyond mortality. BMC Pregnancy Childbirth. 2016;16:45.  (6.99 MB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG. 2016;123(7):1135-41.  (144.71 KB)
Ahmed R, Gafni A, Hutton E, Hu Z, Pullenayegum E, von Dadelszen P, et al.. The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial). Hypertension. 2016;68(4):1049-55.  (470.91 KB)
Akeju D, Oladapo O, Vidler M, Akinmade A, Sawchuck D, Qureshi R, et al.. Determinants of health care seeking behaviour during pregnancy in Ogun State, Nigeria. Reprod Health. 2016;13 Suppl 1:32.  (756.61 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123(7):1143-51.  (153.93 KB)
Burke O, Benton S, Szafranski P, von Dadelszen P, S Buhimschi C, Cetin I, et al.. Extending the scope of pooled analyses of individual patient biomarker data from heterogeneous laboratory platforms and cohorts using merging algorithms. Pregnancy Hypertens. 2016;6(1):53-9.  (821.08 KB)
Khowaja A, Qureshi R, Sawchuck D, Oladapo O, Olalekan A, Orenuga E, et al.. The feasibility of community level interventions for pre-eclampsia in South Asia and Sub-Saharan Africa: a mixed-methods design. Reprod Health. 2016;13 Suppl 1:56.  (3.54 MB)
Robertson J, Lisonkova S, Lee T, De Silva D, von Dadelszen P, Synnes A, et al.. Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation. PLoS One. 2016;11(12):e0168285.  (862.28 KB)
Sheikh S, Qureshi R, Khowaja A, Salam R, Vidler M, Sawchuck D, et al.. Health care provider knowledge and routine management of pre-eclampsia in Pakistan. Reprod Health. 2016;13(Suppl 2):104.  (242.46 KB)
Qureshi R, Sheikh S, Khowaja A, Hoodbhoy Z, Zaidi S, Sawchuck D, et al.. Health care seeking behaviours in pregnancy in rural Sindh, Pakistan: a qualitative study. Reprod Health. 2016;13 Suppl 1:34.  (361.94 KB)
Akeju D, Vidler M, Sotunsa J, Osiberu M, Orenuga E, Oladapo O, et al.. Human resource constraints and the prospect of task-sharing among community health workers for the detection of early signs of pre-eclampsia in Ogun State, Nigeria. Reprod Health. 2016;13(Suppl 2):111.  (295.72 KB)
Cormick G, Betrán A, Ciapponi A, Hall D, Hofmeyr J. Inter-pregnancy interval and risk of recurrent pre-eclampsia: systematic review and meta-analysis. Reprod Health. 2016;13(1):83.  (1.22 MB)
Benton S, McCowan L, Heazell AEP, Grynspan D, Hutcheon J, Senger C, et al.. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016;42:1-8.  (475.29 KB)
Salam R, Qureshi R, Sheikh S, Khowaja A, Sawchuck D, Vidler M, et al.. Potential for task-sharing to Lady Health Workers for identification and emergency management of pre-eclampsia at community level in Pakistan. Reprod Health. 2016;13(Suppl 2):107.  (286.51 KB)
Mol B, Roberts C, Thangaratinam S, Magee LA, de Groot C, Hofmeyr J. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.  (128.83 KB)
Staff A, Redman C, Williams D, Leeson P, Moe K, Thilaganathan B, et al.. Pregnancy and Long-Term Maternal Cardiovascular Health: Progress Through Harmonization of Research Cohorts and Biobanks. Hypertension. 2016;67(2):251-60.  (854.88 KB)
von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;36:83-102.  (389.82 KB)
Duffy J, Hooft Jvan 't, Gale C, Brown M, Grobman W, Fitzpatrick R, et al.. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia. Pregnancy Hypertens. 2016;6(4):274-278.  (336.66 KB)
Easter S, Cantonwine D, Zera C, Lim K-H, Parry S, McElrath T. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia. Am J Obstet Gynecol. 2016;214(3):387.e1-7.  (173.57 KB)
Ryan H, Sharma S, Magee LA, Ansermino JM, MacDonell K, Payne BA, et al.. The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured Review. J Obstet Gynaecol Can. 2016;38(10):909-918.  (304.95 KB)
Vidler M, Ramadurg U, Charanthimath U, Katageri G, Karadiguddi C, Sawchuck D, et al.. Utilization of maternal health care services and their determinants in Karnataka State, India. Reprod Health. 2016;13 Suppl 1:37.  (941.52 KB)
Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, et al.. Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study). Eur J Obstet Gynecol Reprod Biol. 2016;206:105-113.  (412.73 KB)
2015
Nathan H, de Greeff A, Hezelgrave NL, Chappell L, Shennan A. An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2. Blood Press Monit. 2015;20(1):52-5.  (217.35 KB)
Benton S, von Dadelszen P. Are long-term health risks of pre-eclampsia and intrauterine growth restriction really the same?. BJOG. 2015;122(13):1824.  (33.63 KB)
Payne BA, Hutcheon J, Dunsmuir D, Cloete G, Dumont G, Hall D, et al.. Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. J Obstet Gynaecol Can. 2015;37(1):16-24.  (1.11 MB)
Solomon C, Greene M. Control of hypertension in pregnancy--if some is good, is more worse?. N Engl J Med. 2015;372(5):475-6.  (342.05 KB)
Payne BA, Groen H, Ukah V, Ansermino JM, Bhutta ZA, Grobman W, et al.. Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension. Pregnancy Hypertens. 2015;5(4):315-21.  (505.41 KB)
Griffin M, Seed P, Webster L, Myers J, MacKillop L, Simpson N, et al.. Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height. Ultrasound Obstet Gynecol. 2015;46(2):182-90.  (349.22 KB)
Khowaja A, Mitton C, Bryan S, Magee LA, Bhutta ZA, von Dadelszen P. Economic evaluation of Community Level Interventions for Pre-eclampsia (CLIP) in South Asian and African countries: a study protocol. Implement Sci. 2015;10:76.  (1.88 MB)
Hofmeyr J, Seuc A, Betrán A, Purnat T, Ciganda A, Munjanja S, et al.. The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: An exploratory, randomized placebo controlled study. Pregnancy Hypertens. 2015;5(4):273-9.  (318.08 KB)
Hu Y, Blair J, Yuen R, Robinson W, von Dadelszen P. Genome-wide DNA methylation identifies trophoblast invasion-related genes: Claudin-4 and Fucosyltransferase IV control mobility via altering matrix metalloproteinase activity. Mol Hum Reprod. 2015;21(5):452-65.  (1007.58 KB)
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. The hypertensive disorders of pregnancy (29.3). Best Pract Res Clin Obstet Gynaecol. 2015;29(5):643-57.  (227.04 KB)
Magee LA, Namouz-Haddad S, Cao V, Koren G, von Dadelszen P. Labetalol for hypertension in pregnancy. Expert Opin Drug Saf. 2015;14(3):453-61.  (463.16 KB)
Magee LA, Singer J, von Dadelszen P. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372(24):2367-8.  (515.75 KB)
De Silva D, Sawchuck D, von Dadelszen P, Basso M, Synnes A, Liston R, et al.. Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres. J Obstet Gynaecol Can. 2015;37(11):975-87.  (362.1 KB)
Teela K, De Silva D, Chapman K, Synnes A, Sawchuck D, Basso M, et al.. Magnesium sulphate for fetal neuroprotection: benefits and challenges of a systematic knowledge translation project in Canada. BMC Pregnancy Childbirth. 2015;15:347.  (549.75 KB)
von Dadelszen P, Magee LA, Payne BA, Dunsmuir D, Drebit S, Dumont G, et al.. Moving beyond silos: How do we provide distributed personalized medicine to pregnant women everywhere at scale? Insights from PRE-EMPT. Int J Gynaecol Obstet. 2015;131 Suppl 1:S10-5.  (662.6 KB)

Pages